Anti-Counterfeiting Technologies

Assuming that the general concept of parallel importation, both legal and illegal, is common knowledge, one would like to discuss the growth of technologies which seek to provide fool-proof mechanisms against counterfeit products. The need for such technologies is driven by the fact that the counterfeit market is valued at $500 billion and costs the government exchequer a sizable amount. It is estimated that 7% of the world trade is in counterfeit goods. Music, software and luxury goods suffer heavily, […]

Anti-Counterfeiting Technologies Read More »

Scramble for Scrabulous: pricing it right

Some weeks ago, we had reported on the Indian-owned gaming website Scrabulous and infringement allegations by Hasbro, the rights-holders of the legendary board game Scrabble. Imminent closure of the site was predicted, and mourned in advance with much fanfare. There were hints at a possible buyout by Electronic Arts (EA), which owns the online rights for the board game, but nothing was verified. Reports now suggest that rumours of the death of Scrabulous might indeed be exaggerated, and that not

Scramble for Scrabulous: pricing it right Read More »

Spicy Tidbit: Haste makes wasteThe KHPPT adds only securing the handmade product

This post is in furtherance of something I have posted earlier. I had already written about the Government of India trying to get GI protection for pashmina. Kashmir Newz reports that apart from objections put forward by the Pakistan based Rawalpindi Chamber of Commerce a Srinagar based artisan body the Kashmir Handmade Pashmina Promotion Trust (KHPPT) has also filed an objection. The KHPPT objections have reached the Chennai registry unlike those by the Pakistan delegation. “The KHPPT is asking for

Spicy Tidbit: Haste makes wasteThe KHPPT adds only securing the handmade product Read More »

SpicyIP Tidbit: Free Trade Agreement- No smooth sailing here.

The chances of the Free Trade Agreement between India and the EU materializing seem bleak now with differences between the parties continuing after another round of negotiations. As The Hindu reports, “Although both sides have stated that good progress had been made in the first three rounds, officials in the 27-member block European Union feel that signing of the FTA by this year-end was near impossible.” While the parties have postponed the next round of negotiations, officials do not seem

SpicyIP Tidbit: Free Trade Agreement- No smooth sailing here. Read More »

Spicy Tidbit: 2nd day at the Annual Global Forum on Innovation, Creativity and Intellectual Property

Today was the 2nd day of the 2nd Annual Global Forum on Innovation, Creativity and Intellectual Property organised by CII in conjunction with the Department of Industrial Policy and Promotion, GOI and the US India Business Council (Mumbai). The day began with a discussion on “Global trends in IP Protection” where Narendra K. Sabharwal, Deputy Director General, World Intellectual Property Organisation spoke of the following – shift in focus of IP community from protection of IP to promotion and exploitation

Spicy Tidbit: 2nd day at the Annual Global Forum on Innovation, Creativity and Intellectual Property Read More »

Chinese pharma poses serious competition to Indian Pharma: PharmaBiz

PharmaBiz.com reports that Chinese pharmaceutical companies are posing a serious threat to their Indian counterparts. As usual the Chinese who are past-masters at reverse engineering have started manufacturing drugs at prices cheaper than Indian drugs. Active pharmaceutical ingredient (API) units in India have already faced severe competition in the country during the last ten years leading to several units shutting down but the threat now is to the formulations industry. The Indian pharmaceutical industry is lobbying hard to ensure that

Chinese pharma poses serious competition to Indian Pharma: PharmaBiz Read More »

SpicyIP Tidbits: IPR Index

According to an article in the Intellectual Assets Magazine (IAM), Property Rights Alliance (PRA) released its International Property Rights Index (IPRI) Report for the year 2008, with rankings on protection for physical and intellectual property in 115 countries. In IP protection, among emerging economies, India ranks 47th along with Mauritania, with Brazil, China and Russia on 49th, 70th and 82nd positions respectively. Finland topped the rankings with Germany, UK and Japan occupying the next three slots; the US is ranked

SpicyIP Tidbits: IPR Index Read More »

SpicyIP Tidbits: Times Group loses domain name dispute

In a super-quick typosquatting dispute decision, the Times of Money, the online remittance subsidiary of Indian media conglomerate Times Group, has been directed to transfer its two domain names, remit2home.com and remit2home1.com, to remithome Corporation, a U.S. to Philippines online remittance service based in Oakland, California (www.remithome.com), according to this report. The decision came from the US National Arbitration Forum, designated to deal with domain name disputes by the Internet Corporation for Assigned Names and Numbers (ICANN). It ruled on

SpicyIP Tidbits: Times Group loses domain name dispute Read More »

SpicyIP Tidbits: YouTube & T-series heading for out-of-court settlement?

This is what Nikhil Pahwa’s post at contentsutra.com seems to suggest, with the Delhi High Court having given the two parties time to settle their copyright infringement dispute. The next hearing is slated for July, but the general mood at the hearing in late-February gave the impression that the two would prefer dealing outside the confines of the Indian judicial system. Notwithstanding the irony of T-Series suing for copyright infringement, if the settlement were to go through, it would deny

SpicyIP Tidbits: YouTube & T-series heading for out-of-court settlement? Read More »

SpicyIP Tidbits: Lipitor Case

Last week, we had reported that Ranbaxy was prohibited by the Court of Appeal in Netherlands from launching a generic version of Pfizer’s basic Lipitor patent on atorvastatin (EP 247633). In an interesting reversal of fortunes, the same court has invalidated Pfizer’s patent on the enantiomer of atorvastatin (EP 409281) which was challenged by Ranbaxy. Pfizer may prefer an appeal against this ruling. It may be recalled that the Nexium case too deals with patent on S-enantiomer of Omeprazole, namely

SpicyIP Tidbits: Lipitor Case Read More »

Scroll to Top